MARKET NEWS

IN8bio Completes Dosing of First Cohort in Phase 1 Clinical Trial
New BD Benchtop Cell Analyzer Enhances Laboratory Access & Accelerates Scientific Research
ProPhase Labs Acquires Whole Genome Sequencing Company
Crinetics Pharmaceuticals’ Oral ACTH Antagonist Demonstrates Pharmacologic Proof-of-Concept With Dose-Dependent Cortisol Suppression in Single Ascending Dose Portion of Phase 1 Study
Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate
atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions

  FEATURED EDITORIAL

  COMPANY PROFILE

Flex Health Solutions is a global design, development, and manufacturing services provider with nearly 30 years of medical experience across FDA Class I, II, and III products and from simple disposables to smart drug delivery systems and complete immunoassay diagnostic systems. Global experience across 12 industries gives us insight and expertise in the technologies to be integrated into tomorrow’s medical products today. Complete vertical integration under one roof from pellet to packout including inline sterilization and final packaging. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Terumo Blood & Cell Technologies & PhotonPharma Inc. Announce Collaboration to Develop Novel Cancer Immunotherapy

Terumo Blood & Cell Technologies & PhotonPharma Inc. Announce Collaboration to Develop Novel Cancer Immunotherapy

Terumo Blood and Cell Technologies and PhotonPharma Inc. recently announced they have established a memorandum of understanding (MOU) for collaboration to develop Innocell, a novel….

Lykan Bioscience & Vineti Announce Partnership to Advance Cell-Based Therapies From Clinical to Commercialization

Lykan Bioscience & Vineti Announce Partnership to Advance Cell-Based Therapies From Clinical to Commercialization

Lykan Bioscience and Vineti recently announced a partnership to unite Lykan’s purpose-built cell therapy manufacturing capabilities and Vineti’s industry-leading….

Dyadic & Sorrento Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate & C1 Technology for Protein-Based Coronavirus Vaccines & Therapeutics

Dyadic & Sorrento Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate & C1 Technology for Protein-Based Coronavirus Vaccines & Therapeutics

Dyadic International, Inc. and Sorrento Therapeutics, Inc. recently announced the signing of a binding term sheet to enter into a License Agreement to develop and commercialize vaccines, therapeutics, and diagnostics for….

Aptar Pharma Granted Exclusive License Option by Pharmaxis to Develop & Promote High Payload Dry Powder Inhaler

Aptar Pharma Granted Exclusive License Option by Pharmaxis to Develop & Promote High Payload Dry Powder Inhaler

Aptar Pharma recently announced it has entered into an agreement with Pharmaxis under which Aptar Pharma has the option to acquire the worldwide rights to….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

September 1 – Drug Delivery
September 8 – Injection Devices